The presence of migraine and increasing headache pain intensity are associated with higher rates of anxiety, depression, inflammation, and sleep conditions, among other disorders.
Emotions, cognitions, and behaviors are significantly associated with pain severity and pain-related interference in IBD, including pain-specific cognitions and behaviors.
Researchers find that racial differences in pain may be rooted in life experience, rather than intrinsic biology.
The Patient-Reported Outcomes Measurement Information System (PROMIS) assessing physical function and pain interference with computer adaptive tests offers a streamlined, effective approach for measuring self-reported outcomes in patients with chronic low back pain.
Severe vitamin D deficiency was linked to lumbar degenerative disease and low back pain in postmenopausal women.
Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from suicide have decreased.
The FDA has approved the first OTC fixed-dose combination therapy containing ibuprofen and acetaminophen for the temporary relief of minor pain.
Hikma Pharmaceuticals USA announced that the voluntary recall of Ketorolac Tromethamine Injection 30mg/mL vials has been extended to include additional lots.
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
Adding nerve ultrasound to nerve conduction studies improves detection of chronic inflammatory neuropathies in patients with suspected chronic inflammatory neuropathy.
